Przejdź do zawartości
Merck

2-Mercaptoimidazoles, a new class of potent CCR2 antagonists.

Bioorganic & medicinal chemistry letters (2005-02-26)
Guy Van Lomen, Julien Doyon, Erwin Coesemans, Staf Boeckx, Marina Cools, Mieke Buntinx, Bart Hermans, Jean Van Wauwe
ABSTRAKT

We describe the synthesis and SAR of a new class of CCR2 antagonists based on 2-mercaptoimidazole scaffold. The initial lead 1a was optimized to the 3,4-disubstituted analogues 1p-(S) and 1q-(S), which have IC(50) values in the MCP-1 induced Ca-flux below 0.01 microM.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
2-Mercaptoimidazole, 98%